<?xml version="1.0" encoding="UTF-8"?>
<ref id="B157-molecules-26-00431">
 <label>157.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Goncalves</surname>
    <given-names>P.H.</given-names>
   </name>
   <name>
    <surname>High</surname>
    <given-names>F.</given-names>
   </name>
   <name>
    <surname>Juniewicz</surname>
    <given-names>P.</given-names>
   </name>
   <name>
    <surname>Shackleton</surname>
    <given-names>G.</given-names>
   </name>
   <name>
    <surname>Li</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Boerner</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>LoRusso</surname>
    <given-names>P.M.</given-names>
   </name>
  </person-group>
  <article-title>Phase I dose-escalation study of the thioxanthone SR271425 administered intravenously once every 3 weeks in patients with advanced malignancies</article-title>
  <source>Investig. New Drugs</source>
  <year>2008</year>
  <volume>26</volume>
  <fpage>347</fpage>
  <lpage>354</lpage>
  <pub-id pub-id-type="doi">10.1007/s10637-008-9135-2</pub-id>
  <pub-id pub-id-type="pmid">18449472</pub-id>
 </element-citation>
</ref>
